explore -WSS

explore

author：leisure time 2025-09-29 21:25:48 - browse：84587

Diversity in clinical trials concept — Adobe

The persistent lack of diversity among participants in clinical trials is a critical issue that is harming both populations that have long been left out of pivotal medical studies and the entire biomedical research enterprise, according to the authors of a report released Tuesday by the National Academies of Sciences, Engineering and Medicine.

Describing the need to move away from trials that focus largely on white men as “urgent,” the report’s authors called for a paradigm shift that gives less power to institutions that fund and conduct clinical research and more to communities under study. The sternly worded report said funding to include and recruit more diverse participants should be a priority that is enforced and said such investments could eventually lead to massive cost savings as the nation’s health disparities are reduced.

“An equitable clinical research enterprise would include trials and studies that match the demographics of the disease burden under study,” the report said. “However, we remain far from achieving this goal.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： 2 US Navy sailors arrested for allegedly spying for China

entertainment

WSS

Nearly two

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

The mammogram wars are not over

Public health communication lessons from Covid

Biden jokes that Republicans may impeach him because inflation is starting to cool down

2 US Navy sailors arrested for allegedly spying for China

leisure time

explore

hotspot

Apple is now the first public company to be valued at $3 trillion

'Ancient DNA,' 23andMe reveal African American ancestries

Apple is now the first public company to be valued at $3 trillion

Dramatically reducing cancer deaths requires the PASTEUR Act

What does generative AI mean for health care? We asked experts

White House drug shortage group privately met with industry

In Memoriam: Notable people who died in 2023

Biden announces an advanced cancer research initiative

The cancer drug shortage isn’t new — and neither are the solutions

The drug industry sees a key ally in the Senate prevail

hotspot

What Mike Pence has said that could be used in a Donald Trump trial

'The boss' wants server deleted: New allegations emerge in Trump indictment

Timeline: Special counsel's probe into Trump's handling of classified documents

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

Attacks on the drug industry will lead to fewer breakthroughs

An outrageous hospital charge: I paid $710 for an hour of babysitting

focus

hotspot

entertainment

leisure time